Key Events This Week
2 Feb: Q3 FY26 results reveal profit plunge amid rising costs
3 Feb: Stock hits 52-week and all-time low of Rs.123.6
4 Feb: Further decline to new 52-week and all-time low of Rs.123.15
6 Feb: Week closes at Rs.127.40, down 0.78%
Feb 06
BSE+NSE Vol: 1.01 lacs
2 Feb: Q3 FY26 results reveal profit plunge amid rising costs
3 Feb: Stock hits 52-week and all-time low of Rs.123.6
4 Feb: Further decline to new 52-week and all-time low of Rs.123.15
6 Feb: Week closes at Rs.127.40, down 0.78%

GPT Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.123.15 on 4 February 2026, marking a significant drop amid broader market fluctuations and company-specific performance concerns.
Read full news article
GPT Healthcare Ltd, a player in the hospital sector, has reached a new all-time low of Rs.123.15, marking a significant milestone in its ongoing decline. The stock’s performance continues to lag behind both its sector and broader market indices, reflecting persistent pressures on the company’s financial metrics and investor sentiment.
Read full news articleThe latest financial results for GPT Healthcare Ltd for the third quarter of FY26 reveal a complex operational landscape characterized by both revenue growth and significant profitability challenges. The company reported a net profit of ₹9.37 crores, which reflects a notable decline compared to the previous quarter and the same quarter last year. This decline raises concerns about the company's ability to manage costs effectively and convert revenue growth into profit. On the revenue front, GPT Healthcare achieved a growth of 17.56% year-on-year, reaching ₹120.16 crores, marking the highest quarterly revenue in recent history. However, this topline growth was overshadowed by a contraction in operating margins, which fell to 17.24% from 19.13% in the previous quarter and 20.81% year-on-year. The significant margin compression indicates operational inefficiencies that need to be addressed. Additionally, the...
Read full news article
GPT Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.123.6 on 3 Feb 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a continuation of the stock’s underperformance relative to its sector and broader market indices.
Read full news article
GPT Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.123.6 on 3 Feb 2026, marking a significant downturn amid broader market volatility and company-specific performance concerns.
Read full news article
GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article
GPT Healthcare Ltd’s shares plunged to a new all-time low of Rs.123.6 on 3 Feb 2026, marking a significant milestone in the stock’s extended period of decline. The hospital sector stock has underperformed both its sector peers and broader market indices, reflecting persistent pressures on its financial performance and investor sentiment.
Read full news article
GPT Healthcare Ltd, a key player in the hospital sector, has reported a mixed quarterly performance for the period ending December 2025, with record net sales overshadowed by deteriorating profitability and financial health indicators. The company’s financial trend has shifted from negative to very negative, signalling mounting challenges despite top-line growth.
Read full news articlePlease find enclosed herewith link of Audio Call held on Un-Audited Financial Results of Q3 & 9MFY26.
Please find enclosed herewith copy of News Paper publication of Unaudited Financial Results for the 3rd Quarter ended December 31 2025.
Please find press release on Un-Audited Financial Results for Q3 9MFY26 ended December 31 2025.
No Upcoming Board Meetings
GPT Healthcare Ltd has declared 10% dividend, ex-date: 14 Nov 25
No Splits history available
No Bonus history available
No Rights history available